Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study

<table>Median UPDRS-III sub score in the PD, MSA and PSP patients at baseline, and after 1 and 3 years of follow-up. <i>MSA: Multiple System Atrophy, PSP: Progressive Supranuclear Palsy; PD: Parkinson’s Disease. </i></table>

BioMed Research International

fig1

Figure 1

Figure 1: Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study 